Patients with high LGALS3‐expressed HCC exhibited significantly shorter bone‐metastasis‐free survival than those with low LGALS3‐expressed HCC (p < 0.001; Figure 3E). The gene discussed is LGALS3; the disease is hepatocellular carcinoma.